INNV Stock Analysis: Buy, Sell, or Hold?
INNV - InnovAge Holding Corp. Common Stock
$7.87
-0.04 (-0.51%)
▼
5d:
-1.13%
30d:
-12.17%
90d:
+42.06%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
INNV is down 5.3% this week, but smart money is accumulating calls. Top strike: $7.5 2026-05-15 with 158 OI. Call ratio: 92% View Scanner →
Strength: 6.9/10
Get Alerted When INNV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: INNV trading at deep discount. Market pricing in -7.9% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: INNV trading at deep discount. Market pricing in -7.9% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.55
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$10.28
23.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INNV is currently trading at $7.87, which is considered oversold relative to its 30-day fair value range of $7.98 to $9.25. From a valuation perspective, the stock is trading at a discount (Forward PE: 23.1) compared to its historical average (29.6). Remarkably, the market is currently pricing in an annual earnings decline of 7.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, INNV is in a strong uptrend. The price is currently testing key support at $7.69. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $7.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INNV is in a strong uptrend. The price is currently testing key support at $7.69. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $7.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$7.98 -
$9.25
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 11.1% above Wall St target ($7.00)
Fair Price Analysis
30-Day Fair Range
$7.98 -
$9.25
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.01
(12.9%)
Support & Resistance Levels
Support Level
$7.69
Resistance Level
$9.03
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.15
Wall Street Target
$7.00
(-11.1%)
Revenue Growth (YoY)
14.7%
Earnings Growth (YoY)
-87.8%
Profit Margin
0.7%
Valuation Discount vs History
-7.9% cheaper
PE vs Historical
23.2 vs 29.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.9%
(market-implied from PE analysis)
1-Year Target
$7.25
(-8%)
2-Year Target
$6.68
(-15%)
3-Year Target
$6.15
(-22%)
3-Yr Target (if PE normalizes)
(PE: 23→30)
$7.86
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.1, Growth: 25.9%)
$15.72
(+100%)
Base:
(SPY PE: 22.4, Growth: 25.9%)
$15.17
(+93%)
Bear:
(PE: 19.0, Growth: 25.9%)
$12.90
(+64%)
📈
Valuation based on Current Earnings
Forward PE: 13.66 | Forward EPS (Implied): $0.58
Bull Case
$9.61
(+21%)
Analyst growth 15.0%, PE expands to 14.3
Base Case
$7.96
(0%)
Market implied 0.0%, PE stable at 13.7
Bear Case
$6.09
(-24%)
Severe decline -15.0%, PE contracts to 12.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.1 to 29.6
Stabilization Target:
$10.06
(+27.9%)
PE Expansion Potential:
+27.9%
Share & Embed Analysis
Last updated: March 30, 2026 10:26 PM ET
Data refreshes hourly during market hours. Next update: 11:26 PM
Data refreshes hourly during market hours. Next update: 11:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INNV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Anthony Scarbrou…
SELL
33000 shares
2025-11-14
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 62 BUY |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$140 | 54 HOLD |
